公司概覽
業務類別 Diagnostics & Research
業務概覽 Myriad Genetics Inc is a molecular diagnostics and precision medicine company committed to advancing health and well-being for all. The company develops and commercializes molecular tests that help patients and providers uncover genetic insights. Its tests assess the risk of developing disease or disease progression and guide treatment decisions across medical specialties, supporting earlier detection, more precise treatment, and lowering healthcare costs. Its tests include BRACAnalysis CDx, EndoPredict, FirstGene, Foresight, GeneSight, MyChoice CDx, MyRisk (cancer treatment), MyRisk (cancer risk), Prequel, Precise Tumor, Prolaris, and SneakPeek. The company operates in the US and Rest of World, with maximum revenue from the US.
公司地址 322 North 2200 West, Salt Lake City, UT, USA, 84116
電話號碼 +1 801 584-3600
傳真號碼 +1 801 584-3640
公司網頁 https://www.myriad.com
員工數量 2700
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Samraat S. Raha President, Chief Executive Officer and Director 美元 750.00K 24/02/2026
Mr. Mark S. Verratti Chief Operating Officer 美元 552.34K 24/02/2025
Ms. Shereen Solaiman Chief People Officer -- 09/04/2025
Ms. Margaret Ancona Senior Vice President and Chief of Staff -- 09/04/2025
Mr. Kevin Richard Haas Chief Technology Officer -- 09/04/2025
Mr. Dale Muzzey Chief Scientific Officer 美元 499.35K 09/04/2025
Mr. Benjamin R. Wheeler Chief Financial Officer and Principal Accounting Officer -- 24/02/2026
Ms. Jennifer Fox Chief Legal Officer -- 09/04/2025
 
董事會成員
董事會 職務 更新日期
Dr. Heiner Dreismann,PhD Independent Director 24/02/2026
Mr. Mark S. Davis Independent Director 24/02/2026
Ms. S. Louise Phanstiel Chairman of the Board 24/02/2026
Mr. Samraat S. Raha President, Chief Executive Officer and Director 24/02/2026
Dr. Daniel M. Skovronsky, M.D.,PhD Independent Director 24/02/2026
Ms. Colleen F. Reitan Independent Director 24/02/2026
Dr. Lee N. Newcomer, M.D. Independent Director 24/02/2026
Ms. Rashmi Kumar Independent Director 24/02/2026
Mr. Paul M. Bisaro Independent Director 24/02/2026
 
所屬ETF (更新日期: 07/03/2026 04:11)
代號 名稱 佔比% 持有日期
IJRiShares Core S&P Small-Cap ETF6.09%28/02/2026
XBIState Street® SPDR® S&P® Biotech ETF2.64%27/02/2026
THQabrdn Healthcare Opportunities1.17%31/01/2026
SPSMState Street SPDR Port S&P 600 Sm CpETF0.92%27/02/2026
IWNiShares Russell 2000 Value ETF0.84%28/02/2026
IBBiShares Biotechnology ETF0.71%28/02/2026
IJSiShares S&P Small-Cap 600 Value ETF0.56%28/02/2026
FNDASchwab Fundamental U.S. Small CompanyETF0.54%28/02/2026
FESMFidelity Enhanced Small Cap ETF0.51%27/02/2026
SCHASchwab US Small-Cap ETF™0.48%28/02/2026
VTWOVanguard Russell 2000 ETF0.46%31/01/2026
IJTiShares S&P Small-Cap 600 Growth ETF0.37%28/02/2026
VIOOVanguard S&P Small-Cap 600 ETF0.33%31/01/2026
SLYVState Street® SPDR® S&P 600™ Sm CpValETF0.32%27/02/2026
VHTVanguard Health Care ETF0.30%31/01/2026
ESMLiShares ESG Aware MSCI USA Small-Cap ETF0.28%28/02/2026
DFASDimensional US Small Cap ETF0.26%27/02/2026
PRFZInvesco RAFI US 1500 Small-Mid ETF0.23%27/02/2026
SLYGState Street® SPDR® S&P 600™ Sm Cp GrETF0.22%27/02/2026
SLYSPDR® S&P 600 Small Cap ETF0.18%31/05/2023
 1    2    3    4    5  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.